Pharmaceutical News (@medpharm) profile picture

PharmeMed is an exclusive business & career network for professionals within the pharmaceutical and healthcare sector. Join us today today!

Joined June 2009
Abbott Receives Regulatory Approval For Facet Biotech Acquisition: http://tinyurl.com/yedhvbx
1
1
Horse cloning sparks debate in Amerca's breeding stables: http://tinyurl.com/ydxrqg4
Drug companies to target nurses: http://tinyurl.com/yb9tzxj
Teva Pharmaceuticals receives final FDA approval for generic Hyzaar and Cozaar: http://tinyurl.com/yeb837b
Radient Pharmaceuticals Extends Onko-Sure Cancer Test Distribution Partnership for the Market of India: http://tinyurl.com/ycupdsa
India to be among top five pharma innovation hubs by 2020
TargetRx Introduces New Research Capability to Increase Effectiveness of Co-Pay Card Initiatives
Generics will continue their domination on the pharmaceutical market in Central and Eastern Europe until 2011
Hard to Treat Diseases (HTDS) Closes 1 Million Dollar Contract Indian Pharmaceutical
PPD buys BioDuro for $77M in China expansion
US Senators are due to begin today what is likely to be a long and bruising debate on its controversial health care reform bill.
Rheumatoid arthritis patients offered trials at Leighton Hospital to find out if taking statins reduces heart attack and stroke deaths.
New stem cell technology developed at Hebrew University leads to better treatment for complicated bone fractures
Sanofi-Aventis' Anti-Arrhythmic Drug Multaq Receives European Approval
GlaxoSmithKline has signed up to be the 24th sponsor of the London 2012 Games.
Understanding how kangaroos repair their DNA could be the key to preventing skin cancer, according to Australian and Austrian researchers.
GSK is to develop £170m biotech science park in the east of England that can rival the leading US centres of Boston and North Carolina
QM Specials a new pharmaceutical manufacturing company is expected to create 50 new jobs in Lismore, Co Waterford, Ireland.
Vietnam plans to produce an antibiotic to protect people from the H1N1 virus by early 2010, at a price 4.5 times cheaper than Tamiflu.
Goldshield Group Plc (GSD.L: News ), reports ahigher profit for the first half of the year, led by a 7.4% growth in sales.